09 December 2020: Clinical Research
Efficacy and Safety of Image-Guided Intensity-Modulated Radiation Therapy and Volumetric Modulated Arc Therapy Combined with Paclitaxel Liposomes and Cisplatin for Locally Advanced Stage IIB–IIIB Cervical Cancer: A Retrospective Study at a Single Center
Meihua Xie ABE* , Xiuxiu Ding BCE* , Aiyu Chen CF , Huiqin Xiao DF , Xiaoye Wang BD , Youhong Wang AC , Huan Zhang ADG*DOI: 10.12659/MSM.927563
Med Sci Monit 2020; 26:e927563
Table 3 Comparison of immunological indicators of patients in the two studied groups.
| IMRT group (n=63) | VMAT group (n=63) | P-value | |
|---|---|---|---|
| CD3 T cell (%) | |||
| Pretreatment | 56.09±8.18 | 55.38±9.10 | 0.646 |
| Posttreatment | 71.61±13.63 | 72.72±11.14 | 0.618 |
| CD4 T cell (%) | |||
| Pretreatment | 35.13±4.09 | 34.75±4.03 | 0.600 |
| Posttreatment | 47.51±6.47 | 48.88±6.08 | 0.223 |
| CD8 T cell (%) | |||
| Pretreatment | 32.12±4.51 | 31.87±4.69 | 0.761 |
| Posttreatment | 25.61±3.58 | 24.88±3.90 | 0.276 |
| CD4/CD8 ratio | |||
| Pretreatment | 1.06±0.13 | 1.03±0.15 | 0.233 |
| Posttreatment | 2.04±0.29 | 2.08±0.24 | 0.401 |
| IMRT – intensity-modulated radiation therapy; VMAT – volumetric modulated arc therapy. | |||